CONMED Corp. (CNMD)
49.44
+0.32
(+0.64%)
USD |
NYSE |
Sep 02, 16:00
49.44
0.00 (0.00%)
After-Hours: 20:00
CONMED Research and Development Expense (TTM) : 60.63M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 60.63M |
| March 31, 2026 | 59.27M |
| December 31, 2025 | 55.88M |
| September 30, 2025 | 54.16M |
| June 30, 2025 | 53.82M |
| March 31, 2025 | 53.78M |
| December 31, 2024 | 54.43M |
| September 30, 2024 | 55.28M |
| June 30, 2024 | 54.18M |
| March 31, 2024 | 53.66M |
| December 31, 2023 | 52.60M |
| September 30, 2023 | 50.80M |
| June 30, 2023 | 51.10M |
| March 31, 2023 | 49.02M |
| December 31, 2022 | 47.15M |
| September 30, 2022 | 46.29M |
| June 30, 2022 | 44.38M |
| March 31, 2022 | 44.21M |
| December 31, 2021 | 43.56M |
| September 30, 2021 | 43.92M |
| June 30, 2021 | 43.00M |
| March 31, 2021 | 40.38M |
| December 31, 2020 | 40.47M |
| September 30, 2020 | 40.85M |
| June 30, 2020 | 41.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 45.00M |
| December 31, 2019 | 45.46M |
| September 30, 2019 | 43.74M |
| June 30, 2019 | 37.37M |
| March 31, 2019 | 35.55M |
| December 31, 2018 | 32.69M |
| September 30, 2018 | 30.70M |
| June 30, 2018 | 34.34M |
| March 31, 2018 | 32.40M |
| December 31, 2017 | 32.31M |
| September 30, 2017 | 31.56M |
| June 30, 2017 | 31.65M |
| March 31, 2017 | 31.61M |
| December 31, 2016 | 32.25M |
| September 30, 2016 | 31.36M |
| June 30, 2016 | 29.66M |
| March 31, 2016 | 29.15M |
| December 31, 2015 | 27.44M |
| September 30, 2015 | 27.80M |
| June 30, 2015 | 28.06M |
| March 31, 2015 | 27.41M |
| December 31, 2014 | 27.78M |
| September 30, 2014 | 27.11M |
| June 30, 2014 | 27.31M |
| March 31, 2014 | 27.05M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Stryker Corp. | 1.606B |
| Alphatec Holdings, Inc. | 76.69M |
| Baxter International, Inc. | 480.00M |
| Becton, Dickinson & Co. | 1.135B |